Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$225.82 - $368.51 $611,972 - $998,662
-2,710 Closed
0 $0
Q3 2021

Nov 04, 2021

BUY
$221.9 - $484.47 $601,349 - $1.31 Million
2,710 New
2,710 $1.04 Million
Q3 2020

Oct 27, 2020

SELL
$54.34 - $94.85 $10,868 - $18,970
-200 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$29.67 - $80.0 $5,934 - $16,000
200 New
200 $13,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Human Investing LLC Portfolio

Follow Human Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Human Investing LLC with notifications on news.